BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11103236)

  • 1. [Latest progress on chemotherapy for advanced gastric cancer].
    Tahara M; Ohtsu A
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2048-58. PubMed ID: 11103236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controversial issues in chemotherapy for inoperable gastric cancer].
    Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Kitamura T; Azuma M; Saigenji K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1249-55. PubMed ID: 14518402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S-1 for gastric cancer-S-1 monotherapy and its progress].
    Shitara K; Sakata Y; Kudou T; Munakata M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():43-51. PubMed ID: 16897971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy for gastric cancer].
    Baba H; Kakeji Y; Oki E; Tokunaga E; Ushiro S; Watanabe M; Maehara Y
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1881-8. PubMed ID: 14650954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers].
    Sawabu N
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jun; 100(6):645-52. PubMed ID: 12833857
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
    Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
    Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in chemotherapy for advanced gastric cancer].
    Xu RH; Teng KY
    Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current combination chemotherapy containing paclitaxel for advanced, recurrent gastric cancer].
    Emi Y; Kakeji Y; Baba H; Ishida T; Maehara Y
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1978-81. PubMed ID: 15570924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CPT-11 combined chemotherapy for metastatic gastric cancer].
    Narahara H; Sugimoto N; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1973-7. PubMed ID: 15570923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy in advanced gastric cancer--to ensure timely and appropriate switch to subsequent treatment options].
    Yamaguchi K; Shimamura T; Ishikubo T; Fujino K; Tada M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):29-34. PubMed ID: 17220666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint].
    Sasaki T; Koizumi W; Higuchi K; Ishido K; Ae T; Nakatani K; Katada C; Tanabe S; Saigenji K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):988-92. PubMed ID: 17637532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
    Ohtsu A; Shimada Y; Shirao K; Boku N; Hyodo I; Saito H; Yamamichi N; Miyata Y; Ikeda N; Yamamoto S; Fukuda H; Yoshida S;
    J Clin Oncol; 2003 Jan; 21(1):54-9. PubMed ID: 12506170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
    Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M
    Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in the treatment of gastric cancer in Europe.
    Köhne CH; Wils JA; Wilke HJ
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):22-5. PubMed ID: 11200144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical development of chemotherapy for advanced gastric cancer].
    Sato A; Matsukawa M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):186-93. PubMed ID: 17283412
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC).
    Morita S; Baba H; Tsuburaya A; Takiuchi H; Matsui T; Maehara Y; Sakamoto J
    Jpn J Clin Oncol; 2007 Jun; 37(6):469-72. PubMed ID: 17584825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
    Ajani JA
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.
    Ilson D
    J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment strategy for primary gastric cancer with peritoneal dissemination].
    Yoshikawa T; Tsuburaya A; Kobayashi O
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1398-403. PubMed ID: 16227737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.